Physician profile
Shawn Michael Casey
NPI 1568535359
$3,933.53
in general payments reported to CMS, 2019-2025
13 companies · $117 in 2025
The $117 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $218 · 2021: $802 · 2022: $277 · 2023: $2,173 · 2024: $210 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $1,620 · Food and Beverage: $840 · Education: $39.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $1,620.00 |
| Food and Beverage | $839.88 |
| Education | $39.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $1,620.00 | 2023 | |
| Straumann USA LLC | $1,105.38 | 2019-2024 | |
| Acteon INC | $275.00 | 2021 | |
| Biohorizons Implant Systems INC. | $224.65 | 2023-2025 | Biohorizons, Biohorizons Dental Implants |
| Kerr Corporation | $171.52 | 2019-2023 | Tf, Maxcem Elite |
| Nobel Biocare USA | $158.84 | 2023 | Nobelactive |
| Henry Schein, INC. | $105.75 | 2022 | |
| Dentsply Sirona INC | $79.84 | 2021-2022 | |
| Align Technology, INC. | $78.77 | 2023-2024 | Invisalign, Itero Element 5d Plus Lite |
| Voco America INC. | $64.57 | 2025 | Futurabond U, Grandio So, Meron Plus Qm |
| Linvatec Corporation | $17.98 | 2024 | Hall Power |
| Geistlich Pharma, North America, INC. | $16.77 | 2025 | Biomaterials |
| Septodont INC. | $14.46 | 2023 | Biodentine |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Casey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.